Related Experiment Videos
Immunotherapy for cancer: focusing on developing treatments rather than drugs
1Vion Pharmaceuticals Inc, New Haven, CT 06511, USA. msznol@vionpharma.com
Current Opinion in Investigational Drugs (London, England : 2000)
|January 5, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update.
The cancer journal from Scientific American·2000
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010